Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 222-426-8 | CAS number: 3468-11-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian cell study: DNA damage and/or repair
- Type of information:
- experimental study planned
- Justification for type of information:
- TESTING PROPOSAL ON VERTEBRATE ANIMALS
NON-CONFIDENTIAL NAME OF SUBSTANCE:
- Name of the substance on which testing is proposed to be carried out: 1-imino-1H-isoindol-3-amine (Ingrain Blue 2.2)
CONSIDERATIONS THAT THE GENERAL ADAPTATION POSSIBILITIES OF ANNEX XI OF THE REACH REGULATION ARE NOT ADEQUATE TO GENERATE THE NECESSARY INFORMATION:
- Available GLP studies - in vitro methods:
1) Bacterial reverse mutation assay (Ames) according to OECD 471: The outcome of this study was negative, i.e. the test substance is not mutagenic towards bacteria. The study was valid and reliable without restrictions and does not trigger additional testing.
2) Micronucleus study according to OECD 487: The outcome of this study is negative, i.e. the test item did not show clastogenic and/or aneugenic activity. The study was valid and reliable without restrictions and does not trigger additional testing.
3) Mammalian cell gene mutation study, using thymidine kinase gene (mouse lymphoma) according to OECD 490: The result of this study is positive, i.e. clastogenic effects were induced by the test item.
- Weight of evidence: Since at least one positive result was observed, further in vivo testing is needed.
- Available non-GLP studies: not available
- Historical human data: not available
- (Q)SAR: not available
- Grouping and read-across: no read-across candidates identified.
- Substance-tailored exposure driven testing: not applicable
CONSIDERATIONS THAT THE SPECIFIC ADAPTATION POSSIBILITIES OF ANNEXES VI TO X (AND COLUMN 2 THEREOF) OF THE REACH REGULATION ARE NOT ADEQUATE TO GENERATE THE NECESSARY INFORMATION:
All possible adaptation possibilities were considered and none were applicable. Exposure-based waiving could also not be used.
FURTHER INFORMATION ON TESTING PROPOSAL IN ADDITION TO INFORMATION PROVIDED IN THE MATERIALS AND METHODS SECTION:
- Details on study design / methodology proposed:
To gain further insight on the genetic toxicity potential of the test item, we propose to perform an in vivo comet assay (OECD TG 489) on intestinal cells which is an indicator test for DNA lesions. According to Column 2 of Annex VIII, appropriate in vivo mutagenicity studies shall be considered in case of a positive result in any of the genotoxicity studies in Annex VII or VIII. According to the Guidance on Information requirements, Chapter 7.a (2017) for indications of clastogenicity, a micronucleus test, a chromosome aberration test or a Comet assay would be the appropriate follow up test; whereas for indications of gene mutations, a transgenic rodent gene mutation assay, a Comet assay, or in some cases an unscheduled DNA synthesis test. In this case, an in vivo Comet assay is justified according to the Guidance.
The liver is the standard organ of the Comet assay, but if the substance is not absorbed, the liver will not be reached. Therefore it is proposed to add gastro-intestinal tissue as target organ. The stomach is usually first site of contact for substances after oral exposure, although other areas of the gastro- intestinal tract such as the duodenum and jejunum can also be considered as site-of-contact tissues and may be considered more relevant for humans than the rodent glandular stomach. Care should be taken to ensure that such tissues are not exposed to excessively high test substance concentrations, but rather to expected exposure concentrations to avoid false positive reactions (Donovan & Burlinson, 2013). In the case of 1-imino-1H-isoindol-3-amine, the irritation potential should be taken into account for selection of the duodenum or jenunum as target tissues. The substance is classified for Skin irrit. 2 and Eye dam. 1. Cytoxicity in the rat stomach is likely, which may lead to equivocal or false positive reactions if stomach will be evaluated. To avoid these equivoval or false positive reactions, it is considered more appropriate to use the duodenum or jejunum (depending on the experience of the selected Laboratory) as a representative site of first contact but also here dose selection should be carefully done to avoid lesions.
Reference:
Donovan MO & Burlinson B. Maximum dose levels for the rodent comet assay to examine damage at the site of contact or to the gastrointestinal tract. Mutagenesis vol. 28 no. 6 pp. 621–623, Advance Access publication 3 October 2013;
Data source
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 489 (In vivo Mammalian Alkaline Comet Assay)
- Deviations:
- yes
- Remarks:
- with liver and small intestine (duodenum or jejunum, depending on experience of lab) as target tissues.
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian comet assay
Test material
- Reference substance name:
- 1-imino-1H-isoindol-3-amine
- EC Number:
- 222-426-8
- EC Name:
- 1-imino-1H-isoindol-3-amine
- Cas Number:
- 3468-11-9
- Molecular formula:
- C8H7N3
- IUPAC Name:
- 1-imino-1H-isoindol-3-amine
- Test material form:
- solid: particulate/powder
Constituent 1
Results and discussion
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.